Stockscreener 앱 받기
53.42
4.11%
2.11
Palvella Therapeutics Inc 주식(PVLA)의 최신 뉴스
Palvella Therapeutics Inc. Breaks Losing Streak — Is the Trend Reversing2025 Technical Patterns & High Conviction Investment Ideas - beatles.ru
Palvella Therapeutics Inc. stock trend forecastJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Will Palvella Therapeutics Inc. benefit from macro trends2025 Price Action Summary & Free Technical Pattern Based Buy Signals - Newser
Is Palvella Therapeutics Inc. in Accumulation Phase NowMarket Risk Summary & Growth Focused Entry Point Reports - classian.co.kr
Technical Heatmap Flags Palvella Therapeutics Inc. for WatchWeekly Risk Summary & Technical Buy Zone Confirmations - beatles.ru
Using flow based indicators on Palvella Therapeutics Inc.Market Weekly Review & AI Driven Price Predictions - Newser
Palvella Therapeutics Inc. stock momentum explainedPortfolio Performance Report & AI Forecast Swing Trade Picks - Newser
Canaccord Genuity raises Palvella Therapeutics stock price target on strong trial enrollment - Investing.com Canada
Live market analysis of Palvella Therapeutics Inc.Market Activity Summary & Free High Return Stock Watch Alerts - Newser
How hedge fund analytics apply to Palvella Therapeutics Inc. stockEarnings Growth Summary & Consistent Return Strategy Ideas - Newser
Applying Elliott Wave Theory to Palvella Therapeutics Inc.Volume Spike & Proven Capital Preservation Methods - Newser
Will Palvella Therapeutics Inc. stock split in the near futureWeekly Profit Report & Detailed Earnings Play Strategies - Newser
How to track smart money flows in Palvella Therapeutics Inc.July 2025 Opening Moves & Stock Market Timing Techniques - Newser
Will Palvella Therapeutics Inc. stock recover after recent drop2025 Price Action Summary & Weekly High Return Forecasts - Newser
Will Palvella Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsJuly 2025 Big Picture & Growth Focused Stock Reports - Newser
HC Wainwright Forecasts Strong Price Appreciation for Palvella Therapeutics (NASDAQ:PVLA) Stock - Defense World
Palvella Therapeutics Inc. stock volume spike explainedJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - Newser
HC Wainwright Boosts Palvella Therapeutics (NASDAQ:PVLA) Price Target to $75.00 - Defense World
Is Palvella Therapeutics Inc. forming a reversal patternEarnings Miss & Risk Managed Trade Strategies - Newser
Chardan Capital Forecasts Strong Price Appreciation for Palvella Therapeutics (NASDAQ:PVLA) Stock - Defense World
Palvella Therapeutics (NASDAQ:PVLA) Given a $75.00 Price Target by HC Wainwright Analysts - Defense World
Palvella Therapeutics (NASDAQ:PVLA) Given New $75.00 Price Target at HC Wainwright - Defense World
Is Palvella Therapeutics Inc. stock entering bullish territoryPortfolio Update Report & Weekly Hot Stock Watchlists - Newser
Detecting price anomalies in Palvella Therapeutics Inc. with AIEarnings Risk Summary & Detailed Earnings Play Alerts - Newser
Truist Financial Maintains Palvella Therapeutics(PVLA.US) With Buy Rating - 富途牛牛
Truist Financial Sticks to Its Buy Rating for Palvella Therapeutics (PVLA) - The Globe and Mail
Palvella Therapeutics price target raised to $75 from $38 at H.C. Wainwright - MSN
What institutional flow reveals about Palvella Therapeutics Inc.Earnings Summary Report & AI Enhanced Trading Alerts - Newser
Exit strategy if you’re trapped in Palvella Therapeutics Inc.Index Update & Safe Entry Zone Tips - Newser
What makes Palvella Therapeutics Inc. stock price move sharplyWeekly Trend Report & Low Drawdown Momentum Ideas - Newser
Palvella Completes Enrollment in Phase 3 SELVA Trial - MSN
What indicators show strength in Palvella Therapeutics Inc.Trade Ideas & Low Risk Investment Opportunities - Newser
How to read the order book for Palvella Therapeutics Inc.July 2025 Selloffs & Weekly Momentum Picks - Newser
Ranking Palvella Therapeutics Inc. among high performing stocks via toolsMarket Activity Recap & Accurate Technical Buy Alerts - Newser
Visual trend scoring systems applied to Palvella Therapeutics Inc.Portfolio Value Summary & Short-Term Swing Trade Alerts - Newser
Palvella:HC Wainwright Raises Buy Rating, PT to $75 from $38 - AInvest
Palvella Therapeutics: Q2 Earnings Snapshot - Norwalk Hour
Risk vs reward if holding onto Palvella Therapeutics Inc.Weekly Profit Report & Low Drawdown Investment Ideas - Newser
Palvella Therapeutics Advances Rare Disease Pipeline - TipRanks
Palvella Posts Cash Gain and Trial Wins - AOL.com
Palvella Therapeutics price target raised to $60 from $50 at Chardan - TipRanks
Palvella Therapeutics: Strong Financial Position and Clinical Progress Justify Buy Rating with Raised Price Target - TipRanks
Palvella Therapeutics price target raised to $60 from $45 at Stifel - MSN
Positive Buy Rating for Palvella Therapeutics Driven by Promising Phase 3 Trial Developments and Market Potential - TipRanks
Palvella Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Earnings call transcript: Palvella Therapeutics Q2 2025 shows stock decline - Investing.com
0.94%
1.72%
자본화:
|
볼륨(24시간):